Edmond de Rothschild Holding’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Edmond de Rothschild Holding’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-470	Closed	-$29K	–	851
2022 Q3	$29K	Hold	470	–	–	﹤0.01%	719
2022 Q2	$37K	Hold	470	–	–	﹤0.01%	693
2022 Q1	$49K	Hold	470	–	–	﹤0.01%	674
2021 Q4	$51K	Sell	470 -1,360	-74%	-$148K	﹤0.01%	702
2021 Q3	$200K	Sell	1,830 -2,450	-57%	-$254K	﹤0.01%	540
2021 Q2	$401K	Hold	4,280	–	–	0.01%	451
2021 Q1	$394K	Buy	+4,280	New	+$361K	0.01%	404
2016 Q3	–	Sell	-3,635	Closed	-$60K	–	899
2016 Q2	$60K	Buy	+3,635	New	+$58.8K	﹤0.01%	616

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Edmond de Rothschild Holding's HZNP Position: Q4 2022 in Review

Edmond de Rothschild Holding sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 470 shares — an estimated $29K sold.

Edmond de Rothschild Holding first reported a position in HZNP in Q2 2016 and held it in 8 quarters. The position peaked at $401K in Q2 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Edmond de Rothschild Holding reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Edmond de Rothschild Holding sold 470 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $29K.
Edmond de Rothschild Holding first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 8 quarters.
Edmond de Rothschild Holding's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $401K in Q2 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2022, filed 9 Feb 2023.